As part of the $3.7 million grant from the National Institutes of Health, the Cedars-Sinai Regenerative Medicine Institute, directed by Clive Svendsen, Ph.D., will supply scientists at five leading laboratories, including Cedars-Sinai, with all the adult stem cells used in the study.
The consortium comprises a partnership of five leading Huntington's disease laboratories at Cedars-Sinai, the Gladstone Institutes, Johns Hopkins, Massachusetts General Hospital and the University of California at Irvine.
Svendsen, who recently joined the Cedars-Sinai Regenerative Medicine Institute, is a prominent stem cell scientist whose groundbreaking research focuses on both modeling and treating neurodegenerative disorders such as ALS (amyotrophic lateral sclerosis or Lou Gehrig’s disease) and Parkinson’s disease using a combination of stem cells and powerful growth factors. Prior to joining Cedars-Sinai, Svendsen served as director of the National Institutes of Health-funded Stem Cell Training Program at University of Wisconsin-Madison and as editor of the Encyclopedia of Stem Cell Research.
Huntington’s disease, also known as “Huntington's chorea" and "Woody Guthrie's disease," is an incurable neurodegenerative genetic disorder that affects muscle coordination and some cognitive functions, such as memory. It can also affect personality, causing increased confusion and anger. More than 100,000 Americans and 1 million worldwide have Huntington’s or are at risk of inheriting the disease from a parent. Any child of an affected parent has a 50 percent risk of inheriting the disease.
The goal of the project is to compare stem cells from patients with Huntington’s with stem cells from healthy patients in an effort to understand why brain cells die in Huntington’s patients, causing uncontrollable body movements and psychological changes. The project will use induced pluripotent stem cell technology, which enables specialized stem cells to be generated from adults’ skin samples.
“Regenerative medicine could enable us to untangle the mystery of this inexorably fatal disease,” Svendsen said. “One of the problems we have faced is that treatments that work in animals are ineffective in people. Now we have an opportunity to study this disease at a cellular level and collaborate with others dedicated to finding effective treatments.”
The Huntington’s project is the first endeavor announced since Svendsen was selected as director of the Cedars-Sinai Regenerative Medicine Institute, which brings together basic scientists with specialist clinicians, physician scientists and translational scientists across multiple medical specialties to translate fundamental stem cell studies to therapeutic regenerative medicine. The Institute will be housed in new state-of-the-art laboratories being constructed for stem cell and regenerative medicine research. At the heart of the Institute will be a specialized core facility for the production of pluripotent stem cells (capable of making all tissues in the human body) from adult human skin biopsies. Cells produced within the Institute would be used in a variety of Cedars-Sinai Medical research programs (initially focusing on understanding the causes of and finding treatments for diseases of the brain, heart, eye, liver, kidney, pancreas and skeletal structures, as well as cancer and metabolic disorders).
“This grant underscores the leading role Dr. Svendsen and his team is playing in the application of stem cell treatments that offer future hope to patients with degenerative diseases,” said Shlomo Melmed, M.D., Cedars-Sinai’s senior vice president of academic affairs and dean of the medical faculty.
Sally Stewart | prpacific.com
Further reports about: > Cedars-Sinai > Huntington’s > Regenerative Therapien > Stem cell innovation > body movement > brain cell > cell death > cognitive function > degenerative disease > effective treatment > health services > metabolic disorder > methanol fuel cells > neurodegenerative disorder > regenerative medicine > stem cells > supply chain
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
25.04.2018 | Power and Electrical Engineering
25.04.2018 | Medical Engineering
25.04.2018 | Power and Electrical Engineering